Therefore, targeting PDGFRα activation and signaling in APCs may be an interesting avenue to oppose increased adipocyte hyperplasia underlying excessive WAT expansion leading to obesity. The gene discussed is PDGFRA; the disease is obesity due to melanocortin 4 receptor deficiency.